Oceanyx Pharmaceuticals is a novel drug discovery and development company leveraging marine cyanobacteria-based natural product research. Oceanyx was co-founded by Dr. Hendrik Luesch (Debbie & Sylvia DeSantis Chair in Natural Products Chemistry, Professor, Medicinal Chemistry, University of Florida) and a seasoned Boston-based biotech entrepreneur, Dr. Pravin Chaturvedi. In addition to an impressive chemical biology technology platform, the Company has identified multiple novel lead candidates, including largazole, apratoxin S4 and S8. The Company’s lead drug candidates are indicated for the treatment of cancer, bone disorders and/or neurodegenerative disorders.
